Early research (Phase 1)Study completedNCT03234036
What this trial is testing
A Two-part Study to Compare a Tablet and Capsule Formulation of GSK2838232 With and Without Food, and to Assess the Safety and Drug Levels of Repeated Once-daily Doses of GSK2838232 Without Ritonavir
Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
GlaxoSmithKline 26